Project Grant R01DK147191
- Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a $121,500 Project Grant award dated June 15, 2026, from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The project, "The Relationship of Circadian Phase and Functional Abdominal Pain in Adolescents," will conduct a case-control research study examining the relationship between...
- Federal Grant Award Summary Cincinnati Children's Hospital Medical Center received a $824,078 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded April 1, 2026, with completion by January 31, 2030. The grant funds a comprehensive research initiative to characterize drug-induced pancreatic injury (DIPI) through integrated multi-omics analysis,...
- Federal Grant Award Summary Award Overview The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Massachusetts General Hospital (The General Hospital Corporation) a Project Grant totaling $667,788 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective April 1, 2026, through January 31, 2031. The award funds a multidisciplinary research investigation titled "Identifying Multidimensional Signatures of Gastric...
- Federal Project Grant Award Summary Boston Children's Hospital received a $168,543 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026, with a completion date of March 31, 2031. The award funds basic biomedical research investigating the mechanisms of hypothalamic-pituitary-adrenal (HPA) axis suppression and recovery following long-term...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Stony Brook University a $738,152 Project Grant, effective July 1, 2026, through April 30, 2030, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This award funds basic biomedical research investigating IL-17A-mediated regulation of stromal and epithelial cell interactions in the intestine. The research addresses a critical gap in...
- Federal Project Grant Award Summary The University of Kansas Medical Center Research Institute, Inc. received a $171,069 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded May 1, 2026, with a completion date of February 28, 2031. The grant funds the development, refinement, and pilot testing of IMPACT-FBBT, an adjunctive behavioral pain management...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $796,742 Project Grant award on February 6, 2026, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This award funds research to develop and validate a urinary peptidomics-based biomarker panel for risk stratification of neurogenic bladder in spinal bifida patients through...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Nemours Children's Hospital, Delaware a $114,000 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on May 12, 2026, with a completion date of April 30, 2028. The award supports the development of dissemination strategies designed to increase healthcare provider awareness and utilization of evidence-based psychosocial...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of California Irvine $776,971 on June 5, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct translational research on early life stress (ELS), cellular vulnerability, and metabolic disease. The research delivers scientific investigation and biomedical analysis across two complementary tracks: (1) in...
- Federal Grant Award Summary Yale University received an $802,843 Project Grant award dated September 13, 2025, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project, titled "Pathogenic Mechanisms of Obesity and Its Cardiometabolic Complications," will be conducted through June 30, 2030, at Yale's Connecticut facility. This award funds...
Connecticut Children's Medical Center received a $782,101 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded July 1, 2026, with a completion date of March 31, 2031. This multi-center longitudinal study evaluates the relationship between pain-related stigma and long-term health outcomes in adolescents with painful disorders of gut-brain interaction (DGBI-P), including functional dyspepsia, irritable bowel syndrome, functional abdominal pain disorder, and abdominal migraine. The research will assess 230 adolescents (ages 12-17) at multiple time points over 12 months, collecting data on pain-related stigma, disability, psychological distress, social functioning, and physiological stress markers through saliva samples, blood pressure measurements, and body-mass index assessments. The deliverables include longitudinal comparative analyses of pain-related stigma reports against concurrent health outcome assessments and evaluation of the relationship between stigma experiences and allostatic load biomarkers as measures of chronic stress exposure. This research addresses a significant public health priority by examining how negative social judgments of pain conditions interfere with protective supports during adolescence and contribute to delayed diagnosis, impaired recovery, and adverse long-term health outcomes. The findings will advance understanding of stigma's impact on pediatric gastrointestinal disorders and inform interventions to improve clinical outcomes.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $782.1k | 6/23/26 |